Skip to main content

Table 3 Clinical characteristics of patients with postoperative acute exacerbation after initial and second surgeries

From: Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study

Variablea

Initial NĀ =ā€‰6

SecondĀ NĀ =ā€‰3

p Valueb

Age, years

71.3ā€‰Ā±ā€‰8.2

72.7ā€‰Ā±ā€‰8.4

1.000

Sex

ā€ƒMale

6

3

NA

ā€ƒFemale

0

0

Smoking history (PY), mean

50.8ā€‰Ā±ā€‰8.3

78.7ā€‰Ā±ā€‰43.6

0.381

FEV1%, mean

81.9ā€‰Ā±ā€‰5.2

87.5ā€‰Ā±ā€‰11.2

0.393

%VC, mean

78.5ā€‰Ā±ā€‰9.8

64.4ā€‰Ā±ā€‰19.7

0.262

KL-6 (U/ml), mean

1204.4ā€‰Ā±ā€‰638.4

606.3ā€‰Ā±ā€‰279.2

0.143

AE risk score, mean

12.8ā€‰Ā±ā€‰1.2

9.0ā€‰Ā±ā€‰1.7

0.024

ā€ƒLow risk

0

2

Ā 

ā€ƒIntermediate risk

6

1

Ā 

Tumor location

ā€ƒUpper

2

0

0.417

ā€ƒLower

4

3

Surgical procedure

ā€ƒWedge

0

1

0.333c

ā€ƒSegmentectomy

1

2

ā€ƒLobectomy

5

0

Histology

ā€ƒAd

2

1

0.301

ā€ƒSq

4

1

ā€ƒAd-Sq

0

1

Pathological stage

ā€ƒIA

0

1

0.392

ā€ƒIB

4

2

ā€ƒIIA

1

0

ā€ƒIIB

1

0

  1. aCategorical data are expressed as numbers, and continuous data are expressed as means Ā± standard deviation
  2. bValues of pĀ <ā€‰0.05 are significant
  3. cValue is a comparison between wedge vs. segmentectomy and lobectomy
  4. NA not available, PY pack year, FEV1 forced expiratory volume in 1Ā s, VC vital capacity, KL-6 sialylated carbohydrate antigen KL-6, AE acute exacerbation, Ad adenocarcinoma, Sq squamous cell carcinoma, Ad-Sq adenosquamous cell carcinoma